Mesoblast Partners With Cartherics to Develop ‘off-the-shelf’ Cell-based Immunotherapies for Solid CancersRelapsed … – Markets Insider
|
Mesoblast Partners With Cartherics to Develop 'off-the-shelf' Cell-based Immunotherapies for Solid CancersRelapsed …
Markets Insider NEW YORK and MELBOURNE, Australia, May 29, 2018 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) today announced that it has entered into a partnership with Cartherics Pty Ltd to develop allogeneic 'off-the-shelf' CAR–T cells … |
